Hyperpigmentation induced by topical 5-aminolaevulinic acid plus visible light(470 views) Monfrecola G, Procaccini EM, D'Onofrio D, Roberti G, Liuzzi R, Staibano S, Manco A, De Rosa G, Santoianni P
Keywords: 5-Aminolaevulinic Acid, Melanogenesis, Photodynamic Therapy, Visible Light, Aminolevulinic Acid, Photosensitizing Agent, Protoporphyrin, Adult, Article, Colorimetry, Concentration (parameters), Condyloma, Controlled Study, Cream, Drug Effect, Drug Formulation, Drug Penetration, Electron Microscopy, Erythema, Female, Fluorescence Analysis, Histopathology, Human, Human Experiment, Human Tissue, Hyperpigmentation, Immunohistochemistry, In Vivo Study, Irradiation, Melanocyte, Normal Human, Priority Journal, Protective Clothing, Psoriasis, Radiation Dose, Skin Cancer, Skin Discoloration, Skin Edema, Skin Penetration, Verruca Vulgaris, Chemically Induced Disorder, Middle Aged, Photochemotherapy, Radiation Exposure, Topical Drug Administration, Ultrastructure,
Affiliations: *** IBB - CNR ***
Department of Dermatology, University Federico II, Via S. Pansini 5, 80131 Napoli, Italy
Dept. of Biomorphol./Function. Sci., Section of Pathology, University Federico II, Napoli, Italy
Department of Physic Science, Nat'l. Inst. of Fisica della Materia, Napoli, Italy
References: Jones, C.M., Mang, T., Cooper, M., Wilson, B.D., Stoll, H.L., Photodynamic Therapy in the treatment of Bowen's disease (1992) J. Am. Acad Dermatol., 27, pp. 979-98
Dougherty, T.J., Photoradiation therapy for cutaneous and subcutaneous malignancies (1981) J. Invest. Dermatol., 77, pp. 122-124
McCaughan, J.S., Guy, J.T., Hicks, W., Laufmann, L., Nims, T.A., Walker, J., Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms (1989) Arch. Surg., 124, pp. 211-216
Buchanan, R.B., Carruth, J.A.S., Mckenzie, A.L., Rhys Williams, S., Photodynamic therapy in the treatment of malignant tumours of the skin of head and neck (1989) Eur. J. Surg. Oncol., 15, pp. 400-406
Wolf, P., Rieger, E., Kerl, H., Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolaevulinic acid (1993) J. Am. Acad. Dermatol., 28, pp. 17-21
Calzavara-Pinton, P.G., Repetitive photodynamic therapy with topical δ-aminolaevulinic acid as an appropriate approach to routine treatment of superficial non-melanoma, skin tumours (1995) J. Photochem. Photobiol. B: Biol., 29, pp. 53-57
Wolf, P., Fink-Puches, R., Cerroni, L., Kerl, H., Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolaevulinic acid (1994) J. Am. Acad. Dermatol., 31, pp. 678-680
Boehncke, W.H., Sterry, W., Kaufmann, R., Treatment of psoriasis by topical photodynamic therapy with polychromatic light (1994) Lancet, 343, p. 801
Monfrecola, G., D'Anna, F., Delfino, M., Topical haematoporphyrin plus UVA for treatment of alopecia areata (1987) Photodermatol. Photoimmunol. Photomed., 4, pp. 305-306
Stringer, M.R., Collins, P., Robinson, D.J., Stables, G.I., Sheehan-Dare, R.A., The accumulation of Protoporphyrin IX in plaque psoriasis after application of 5-aminolaevulinic acid indicates a potential for superficial photodynamic therapy (1996) J. Invest. Dermatol., 107, pp. 76-81
Ross, E.V., Romero, R., Kollias, N., Crum, C., Anderson, R.R., Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5 -aminolaevulinic acid: Implications for photodynamic treatment (1997) Br. J. Dermatol., 137, pp. 736-742
Monfrecola, G., Mangone, S., Procaccini, E.M., Santoianni, P., Topical administration of haematoporphyrin derivative and red light irradiation, A therapeutic approach in psoriasis (1988) G. Ital. Dermatol. Venereol., 123, pp. 671-674
Kennedy, J.C., Pottier, R.H., Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy (1992) J. Photochem. Photobiol. B: Biol., 14, pp. 275-292
Loh, C.S., MacRobert, A.J., Bedwell, J., Regula, J., Krasner, N., Brown, S.G., Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy (1993) Br. J. Cancer, 68, pp. 41-51
Colasanti, A., Colasanti, P., Fabbrocini, G., Liuzzi, R., Quarto, M., Colasanti, P., Roberti, G., Villani, F., Non-invasive spectroscopic analysis of dermatological lesions excited with N2 laser (1995) SPIE, pp. 77-89. , 2627
Gilchrest, B.A., Park, H.Y., Eller, M.S., Yaar, M., Mechanisms of ultraviolet light-induced pigmentation (1996) Photochem. Photobiol., 63, pp. 1-10
Park, H.Y., Perez, J.M., Laursen, R., Hara, M., Gilchrest, B.A., Protein kinase C-beta activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain (1999) J. Biol. Chem., 274, pp. 16470-16478
Wolf, P., Photodynamische therapie (PDT) (1997) Hautarzt, 48, pp. 137-148
Pass, H.I., Photodynamic therapy in oncology: Mechanisms and clinical use (1993) J. Natl. Cancer Inst., 85, pp. 443-456
Doughert, T.J., Marcus, S.L., Photodynamic therapy (1992) Eur. J. Cancer, 28 A, pp. 1734-1742
Specht, K.G., Rodgers, M.A.J., Depolarization of mouse myeloma cell membranes during photodynamic action (1990) Photochem. Photobiol., 51, pp. 319-324
Agarwal, M.L., Larkin, H.E., Zaidi, S.I.A., Mukhtar, H., Oleinick, N.I., Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma (1993) Cancer Res., 53, pp. 5897-5902
Rhee, S.G., Suh, P.G., Ryu, S.H., Lee, S.Y., Studies of inositol phospholipid-specific phospholipase C (1989) Science, 244, pp. 546-550
Boni, R., Heizmann, C.W., Doguoglu, A., Ilg, E.C., Schafer, B.W., Drummer, R., Ca2+-binding proteins S 100 A6 and S 100 B in primary cutaneous melanoma (1997) Cutan. Pathol., 24, pp. 76-80
Hagen, E.C., Vennegoor, C., Schlingemann, R.O., Van Der Velde, E.A., Ruiter, D.J., Correlation of histopathological characteristics with staining patterns in human melanoma assessed by (monoclonal) antibodies on paraffin sections (1986) Histopathology, 10, pp. 619-700
Bacchi, C.E., Bonetti, F., Pea, M., Martiglioni, G., Gown, A.M., HMB-45. A review (1996) Appl. Immunohistochem., 4, pp. 73-85
Jones, C. M., Mang, T., Cooper, M., Wilson, B. D., Stoll, H. L., Photodynamic Therapy in the treatment of Bowen's disease (1992) J. Am. Acad Dermatol., 27, pp. 979-98
Dougherty, T. J., Photoradiation therapy for cutaneous and subcutaneous malignancies (1981) J. Invest. Dermatol., 77, pp. 122-124
McCaughan, J. S., Guy, J. T., Hicks, W., Laufmann, L., Nims, T. A., Walker, J., Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms (1989) Arch. Surg., 124, pp. 211-216
Buchanan, R. B., Carruth, J. A. S., Mckenzie, A. L., Rhys Williams, S., Photodynamic therapy in the treatment of malignant tumours of the skin of head and neck (1989) Eur. J. Surg. Oncol., 15, pp. 400-406
Boehncke, W. H., Sterry, W., Kaufmann, R., Treatment of psoriasis by topical photodynamic therapy with polychromatic light (1994) Lancet, 343, p. 801
Stringer, M. R., Collins, P., Robinson, D. J., Stables, G. I., Sheehan-Dare, R. A., The accumulation of Protoporphyrin IX in plaque psoriasis after application of 5-aminolaevulinic acid indicates a potential for superficial photodynamic therapy (1996) J. Invest. Dermatol., 107, pp. 76-81
Ross, E. V., Romero, R., Kollias, N., Crum, C., Anderson, R. R., Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5 -aminolaevulinic acid: Implications for photodynamic treatment (1997) Br. J. Dermatol., 137, pp. 736-742
Kennedy, J. C., Pottier, R. H., Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy (1992) J. Photochem. Photobiol. B: Biol., 14, pp. 275-292
Loh, C. S., MacRobert, A. J., Bedwell, J., Regula, J., Krasner, N., Brown, S. G., Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy (1993) Br. J. Cancer, 68, pp. 41-51
Gilchrest, B. A., Park, H. Y., Eller, M. S., Yaar, M., Mechanisms of ultraviolet light-induced pigmentation (1996) Photochem. Photobiol., 63, pp. 1-10
Park, H. Y., Perez, J. M., Laursen, R., Hara, M., Gilchrest, B. A., Protein kinase C-beta activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain (1999) J. Biol. Chem., 274, pp. 16470-16478
Pass, H. I., Photodynamic therapy in oncology: Mechanisms and clinical use (1993) J. Natl. Cancer Inst., 85, pp. 443-456
Doughert, T. J., Marcus, S. L., Photodynamic therapy (1992) Eur. J. Cancer, 28 A, pp. 1734-1742
Specht, K. G., Rodgers, M. A. J., Depolarization of mouse myeloma cell membranes during photodynamic action (1990) Photochem. Photobiol., 51, pp. 319-324
Hames, B. D., Glover, D. M., (1996) Molecular Immunology, , (Eds.), IRL Press, Oxford
Agarwal, M. L., Larkin, H. E., Zaidi, S. I. A., Mukhtar, H., Oleinick, N. I., Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma (1993) Cancer Res., 53, pp. 5897-5902
Rhee, S. G., Suh, P. G., Ryu, S. H., Lee, S. Y., Studies of inositol phospholipid-specific phospholipase C (1989) Science, 244, pp. 546-550
Hagen, E. C., Vennegoor, C., Schlingemann, R. O., Van Der Velde, E. A., Ruiter, D. J., Correlation of histopathological characteristics with staining patterns in human melanoma assessed by (monoclonal) antibodies on paraffin sections (1986) Histopathology, 10, pp. 619-700
Bacchi, C. E., Bonetti, F., Pea, M., Martiglioni, G., Gown, A. M., HMB-45. A review (1996) Appl. Immunohistochem., 4, pp. 73-85
Hyperpigmentation induced by topical 5-aminolaevulinic acid plus visible light